Taft Commends Roxane Laboratories for Creating Jobs for Ohioans
COLUMBUS, OHIO (September 23, 2003) - Governor Bob Taft today helped cut the ribbon for Roxane Laboratories' new pharmaceutical manufacturing facility. The company will produce their Spiriva product line in the facility, creating 95 new jobs.
"Roxane Laboratories is creating the kind of jobs we are working to grow through the Third Frontier Project," Taft said. "I'm thrilled that Roxane Laboratories chose to manufacture their new Spiriva product line here in Ohio, and, as a result, will create 95 good jobs for our citizens."
Roxane Laboratories is a worldwide leader in the manufacture and sale of generic pharmaceuticals. Their affiliated parent company, Boehringer Ingelheim Pharmaceuticals, Inc., is a multi-billion dollar pharmaceutical company with operations in 61 countries, and affiliated companies in 140 countries.
In 2002, Taft led a Business Mission to Europe where he met with Boehringer Ingelheim and discussed the Spiriva expansion project. Ohio was in direct competition with Germany for the project.
Through the Ohio Department of Development (ODOD), the State of Ohio has provided the following incentives for the Spiriva project:
? A $150,000 business development grant;
? $120,000 in Ohio Investment Training Program Funds; and
? A 65 percent, 10-year Job Creation Tax Credit;
"If we are going to succeed today and tomorrow in the new knowledge economy, terms like bioscience and fuel cells and polymers must become part of our everyday vocabulary," said Taft. "Ohio must be the place where new knowledge is used to create new products, new businesses, new companies and new jobs. And that's what our Third Frontier Project is all about."
The Third Frontier Project is Taft's $1.6 billion job creation program to expand Ohio's high-tech research capabilities and promote start-up companies to create high-paying jobs for generations to come.
For more information on the Third Frontier Project and ODOD incentive programs, visit www.odod.state.oh.us.
